Home - Products - Angiogenesis - JAK - TG-46

TG-46

CAS No. 936091-15-5

TG-46( —— )

Catalog No. M33688 CAS No. 936091-15-5

TG-46 (TG46) inhibits JAK2, FLT3, RET, JAK3 and can be used to study glaucoma.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	296	Get Quote
5MG	409	Get Quote
10MG	618	Get Quote
25MG	1021	Get Quote
50MG	1546	Get Quote
100MG	2286	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

TG-46
Note

Research use only, not for human use.
Brief Description

TG-46 (TG46) inhibits JAK2, FLT3, RET, JAK3 and can be used to study glaucoma.
Description

JAK-IN-35 (compound TG46) is a JAK2 inhibitor that canb be used in cancer research.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

JAK
Recptor

JAK | FLT
Research Area

——
Indication

——

Chemical Information

CAS Number

936091-15-5
Formula Weight

510.65
Molecular Formula

C26H34N6O3S
Purity

>98% (HPLC)
Solubility

——
SMILES

Cc1cnc(Nc2ccc(CN3CCOCC3)cc2)nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Wenge Zhu, et al. Combination therapy for treating cancer. Patent WO2018187485A1.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

SAR-20347

SAR-20347 (SAR20347) is a potent, selective inhibitor of JAK1 and Tyk2 with IC50 of 59 and 13 nM in TR-FRET assays.
FM-381

FM-381 (FM381) is a potent, specific, reversible and covalent inhibitor of JAK3 with IC50 of 127 pM.
CYT387

A potent and selective JAK1/JAK2 inhibitor with IC50 of 11/18 nM.

Sign In Join Free